Fighting Amyotrophic Lateral Sclerosis by Protecting the Liver? A Prospective Cohort Study
Authors:
- 19 October 2024
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 97 (2) , 270-280
Abstract
Background: Previous studies have observed liver abnormalities in amyotrophic lateral sclerosis (ALS) patients. This study aimed to investigate whether early signs of liver disease, measured by magnetic resonance imaging‐derived iron‐corrected T1‐mapping (cT1), are risk factors for developing ALS.Methods: cT1 and proton density fat fraction were measured and automatically analyzed using LiverMultiScan® software. The Fibrosis‐4 index was calculated using an established formula based on age and blood markers. Cox proportional hazard models were used to examine the relationship between liver disease, liver biomarkers, and incident ALS.Results: In a cohort of 533,707 individuals from UK Biobank, 24 ALS cases were identified among 28,328 participants with liver disease during the follow‐up period. Among a total of 33,959 individuals with complete liver imaging data, 15 incident ALS cases were observed during a median follow‐up period of 5.6 years. Individuals with liver disease had a higher risk of developing ALS, with an adjusted hazard ratio of 7.35 (95% CI 4.47–12.09; p < 0.001). An increase in cT1 was also associated with a higher risk of ALS. After adjusting for age, sex, Townsend deprivation index, smoking status, alcohol intake frequency, body mass index, proton density fat fraction, Fibrosis‐4, and metabolic syndrome, an increase in cT1 remained significantly associated with a higher risk of ALS, with an adjusted hazard ratio of 3.15 (95% CI 1.79–5.55) per 1‐SD increase. Sensitivity analyses confirmed these robust results.Interpretation: Liver disease activity, indicated by cT1, increases the risk of developing ALS, independent of metabolic syndrome, liver fat, or fibrosis. ANN NEUROL 2025;97:270–280Keywords
Funding Information
- National Natural Science Foundation of China (12101460, 81901273)
- Natural Science Foundation of Zhejiang Province (ZCLY24H0903)
This publication has 58 references indexed in Scilit:
- Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degenerationAnnals of Clinical and Translational Neurology, 2023
- Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virusAbdominal Radiology, 2020
- Multiparametric MRI in Patients With Nonalcoholic Fatty Liver DiseaseJournal of Magnetic Resonance Imaging, 2020
- Life Course Adiposity and Amyotrophic Lateral Sclerosis: A Mendelian Randomization StudyAnnals of Neurology, 2020
- Abnormal fatty acid metabolism is a core component of spinal muscular atrophyAnnals of Clinical and Translational Neurology, 2019
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- Activity and expression of glutathione S-transferase pi in patients with amyotrophic lateral sclerosisClinica Chimica Acta, 2006
- Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue DamageClinical Immunology, 2001
- Hepatic Ultrastructural Changes and Liver Dysfunction in Amyotrophic Lateral SclerosisArchives of Neurology, 1987
- Functional and morphometric study of the liver in motor neuron diseaseJournal of Neurology, 1985